Clinical Trial Update: Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of 5-azacitidine and lenalidomide in myelodysplastic syndromes and acute myeloid leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• 5-Azacitidine (azacitidine)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Myelodysplastic Syndromes, Acute Myelogenous Leukemia | Phase 1 | Status: TERMINATED